Locations:
Search IconSearch
August 20, 2018/Cancer/Research

Featured Cancer Clinical Trials

Search our Cancer Clinical Trials Database for a full listing of all open and accruing studies

Clinical-Trial-690×380

Solid Tumors
CASE 2Y15
Identifying and overcoming barriers to precision oncology among racial and ethnic minorities.
View full trial information.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Prostate Cancer
CASE 3815
The effectiveness of a proposed Prostate Cancer outreach program in a predominantly African American community that promotes informed decision-making for prostate cancer screening and utilizes community navigation.
View full trial information.

Head and Neck Cancer
CASE 6316
A Phase II Study of the Addition of Pembrolizumab to Postoperative Radiotherapy in Resected High Risk Cutaneous Squamous Cell Cancer of the Head and Neck.
View full trial information.

CAR T-cell Therapy
CASE 11Z18
This study aims to develop a repository of blood samples from patients receiving CAR T-cell therapy at the Cleveland Clinic.
View full trial information.

Leukemia, Acute Myeloid (AML)
MNGP 1917
A Phase I/II Study of SEL24 in Patients with Acute Myeloid Leukemia; CLI24-001.
View full trial information.

Multiple Myeloma
JAN 2A17
A Phase 3 Randomized, Multicenter Study of Subcutaneous Daratumumab Versus Active Monitoring in Subjects with High-risk Smoldering Multiple Myeloma
View full trial information.

Leukemia, Acute Myeloid (AML), Leukemia, Chronic Myeloid (CML), Myelofibrosis, Myeloproliferative Neoplasms
MCC 1917
A Phase 1b/2 Study to Evaluate the Safety and Efficacy of APR-246 in Combination with Azacitidine for the Treatment of TP53 Mutant Myeloid Neoplasms.
View full trial information.

Search our Cancer Clinical Trials Database for a full listing of all open and accruing studies.

Advertisement

Related Articles

Doctors working on MGUS screening study
March 18, 2024/Cancer/Research
Pilot Study Aims for Early Identification of Multiple Myeloma Precursor Among Black Patients

First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses

Hematologist at Cleveland Clinic
March 14, 2024/Cancer/Blood Cancers
Advances in Mantle Cell Lymphoma Treatment (Podcast)

Global R&D efforts expanding first-line and relapse therapy options for patients

Physician with patient
March 6, 2024/Cancer/Research
Targeting Uncontrolled Erythrocytosis in Polycythemia Vera with Rusfertide

Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels

Dr. Jagadeesh at Cleveland Clinic
February 28, 2024/Cancer/Blood Cancers
Treating Patient with Systemic T-Cell Lymphoma and Graft-Versus-Host Disease

A case study on the value of access to novel therapies through clinical trials

Doctor measuring patient's waist size
February 26, 2024/Cancer/Research
Impact of Obesity on GVHD & Transplant Outcomes in Hematologic Malignancies

Findings highlight an association between obesity and an increased incidence of moderate-severe disease

Physician with patient
February 21, 2024/Cancer/Research
Strategies for Improving Clinical Trial Equity

Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456

How antibody drug conjugates work
February 13, 2024/Cancer/Research
Real-World Use of Trastuzumab Deruxtecan

Key learnings from DESTINY trials

CQD-4445459-rotz-650×450
February 7, 2024/Cancer
Advances in Bone Marrow Transplant Have Improved Outcomes in Fanconi Anemia

Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients

Ad